Paper28257580
A Novel Antifibrotic Mechanism of Nintedanib and Pirfenidone. Inhibition of Collagen Fibril Assembly.
Knüppel L and 9 others. Am J Respir Cell Mol Biol, 2017. Cited by 155 papers, by iCite.
Cite this record
ConductScience Library. A Novel Antifibrotic Mechanism of Nintedanib and Pirfenidone. Inhibition of Collagen Fibril Assembly. Papers, record 28257580. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28257580
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A Novel Antifibrotic Mechanism of Nintedanib and Pirfenidone. Inhibition of Collagen Fibril Assembly.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fibrillar Collagens | Major topic |
| Idiopathic Pulmonary Fibrosis | Major topic |
| Indoles | Major topic |
| Pyridones | Major topic |
| Collagen Type I | |
| Down-Regulation | |
| Extracellular Matrix Proteins | |
| Fibroblasts | |
| HSP47 Heat-Shock Proteins | |
| Humans | |
| Lung | |
| Protein Processing, Post-Translational | |
| Tacrolimus Binding Proteins | |
| Transcription, Genetic |
Source PubMed
Cited by107
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 155 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42768179 | Understanding and targeting the tumour matrisome. | Nat Rev Clin Oncol | 2026 | https://conductscience.org/library/papers/42768179 | PubMed |
| 42737546 | Non-Resolving Repair in Idiopathic Pulmonary Fibrosis: From Failed Cellular Transitions to Architectural Lock-In. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42737546 | PubMed |
| 42712523 | An hiPSC-derived multi-lineage lung model exhibiting proximal-distal epithelial features for modeling pulmonary fibrosis. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42712523 | PubMed |
| 42650804 | In Vitro Assessment of Nintedanib in Keratoconus Corneal Stromal Microenvironment. | Biomolecules | 2026 | https://conductscience.org/library/papers/42650804 | PubMed |
| 42630570 | The mechano-immunological barrier in fibrosis-associated lung cancer: targeting matrix stiffness and the Piezo1 axis for microenvironment normalization. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42630570 | PubMed |
| 42548660 | Fibrotic remodeling in the NOD/ShiLtJ mouse model of Sjögren's disease: insights from single-cell transcriptomics and AI-driven ECM quantification. | Front Immunol | 2026 | https://conductscience.org/library/papers/42548660 | PubMed |
| 42353052 | Evaluation and Comparison of Treatment with Polymerised Collagen or Pirfenidone as Stand-Alone Therapy on the Production of Profibrotic Factors in Tracheal Stenosis and Tracheal Anastomosis Scarring After Resection. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42353052 | PubMed |
| 42004996 | Therapeutic Potential of Lentiviral miR-200a Mimics in Regulating Fibrinolysis and EMT Markers During Pulmonary Fibrosis. | FASEB Bioadv | 2026 | https://conductscience.org/library/papers/42004996 | PubMed |
| 41932442 | Prolyl-3-hydroxylase 1 is a central regulator of collagen post-translational modifications and the collagen biosynthetic network. | J Biol Chem | 2026 | https://conductscience.org/library/papers/41932442 | PubMed |
| 41665665 | The emerging role of pancreatic exocrine fibrosis as a common aetiological driver of islet dysfunction and diabetes: opportunities for novel disease-modifying interventions. | Diabetologia | 2026 | https://conductscience.org/library/papers/41665665 | PubMed |
| 41557237 | Collagen in Fibrotic Diseases. | Subcell Biochem | 2026 | https://conductscience.org/library/papers/41557237 | PubMed |
| 41437121 | The tumour immune microenvironment is enriched but suppressed in vestibular schwannoma compared to meningioma: therapeutic implications for NF2-related schwannomatosis. | Acta Neuropathol Commun | 2025 | https://conductscience.org/library/papers/41437121 | PubMed |
| 41312367 | Advances in interleukin-10-based therapies for pulmonary diseases: focus on targeted lung delivery systems. | Front Immunol | 2025 | https://conductscience.org/library/papers/41312367 | PubMed |
| 41223415 | Mechanobiology and Resolution of Lung Fibrosis. | Annu Rev Physiol | 2026 | https://conductscience.org/library/papers/41223415 | PubMed |
| 41158711 | Biofabrication of a 3D human skeletal muscle microenvironment to study the early steps of fibrosis. | Mater Today Bio | 2025 | https://conductscience.org/library/papers/41158711 | PubMed |
| 41080967 | Small airway disease as a key factor in COPD: new perspectives and insights. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/41080967 | PubMed |
| 40989087 | Exploring the Influence of Metabolic Changes in Fibrotic Lung Diseases. | Pulm Circ | 2025 | https://conductscience.org/library/papers/40989087 | PubMed |
| 40782923 | Biomaterial-based 3D human lung models replicate pathological characteristics of early pulmonary fibrosis. | Acta Biomater | 2025 | https://conductscience.org/library/papers/40782923 | PubMed |
| 40753090 | Inhibition of epithelial cell YAP-TEAD/LOX signaling attenuates pulmonary fibrosis in preclinical models. | Nat Commun | 2025 | https://conductscience.org/library/papers/40753090 | PubMed |
| 40676074 | Enhanced THBS2 promotes collagen synthesis and inflammatory secretome of fibroblasts in idiopathic pulmonary fibrosis. | Sci Rep | 2025 | https://conductscience.org/library/papers/40676074 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| FKBP10 | 60681 | PubTator's text mining | https://conductscience.org/library/genes/60681 | NCBI Gene |
| FN1 | 2335 | PubTator's text mining | https://conductscience.org/library/genes/2335 | NCBI Gene |
| SERPINH1 | 871 | PubTator's text mining | https://conductscience.org/library/genes/871 | NCBI Gene |
| TGFB1 | 7040 | PubTator's text mining | https://conductscience.org/library/genes/7040 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28257580
GET https://conductscience.org/api/papers/v1/28257580/cited_by?page=2